Immunotherapy for breast cancer Doctors Abroad — Page 2

The doctor is a highly qualified medical oncologist specializing in breast cancer across all clinical stages, including curative and palliative care. With a medical degree from the Pontificia Universidad Católica del Ecuador and a five-year residency at Hospital de la Santa Creu i Sant Pau, the doctor holds a Master's Degree in Medical Oncology from the Spanish Society of Medical Oncology (SEOM).

Currently practicing at the International Breast Cancer Center (IBCC) and IOB Institute of Oncology Barcelona, the doctor has extensive experience in Phase I clinical trials and research. Clinical expertise extends to neuroendocrine tumors, gynecological cancers, and immunotherapy for non-small cell lung cancer. The doctor is an active member of SEOM and ESMO.

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads immunotherapy research and treatment.

• Over 26 years of experience specializing in oncology
• Primary researcher in phase 1-3 clinical trials
• Trained at Ichilov Hospital's renowned oncology department
• Board-certified in both internal medicine and oncology

Dr. Amir specializes in immunotherapy for breast cancer, including targeted therapy with Keytruda (Pembrolizumab). His work includes over 30 presentations at scientific meetings.

• Recipient of ESMO Breast Cancer Translational Research Award
• Fellowship in Breast Cancer Research at Emory University
• Member of European Society of Medical Oncology (ESMO)
• Published researcher with multiple Best Paper awards

Professor of Medical Oncology with over 29 years of experience of experience at Gayrettepe Florence Nightingale Hospital.

• Specializes in gastrointestinal oncology
• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and Turkish Medical Oncology Association

Specializes in immunotherapy for breast cancer with a focus on molecular diagnostics and targeted therapies at Medical Center in Solingen.

• Chief Physician at a certified interdisciplinary cancer center
• Expert in molecular biology research for cancer treatment
• Member of German and American oncology societies
• Qualified specialist in genetics and palliative care

Dr. Séverine Iborra leads the gynecology department at Städtisches Klinikum Solingen, with a focus on oncological diagnostics and breast cancer treatment.

• Certified in gynecological oncology with specialized training in immunotherapy
• Active member of leading German gynecological societies
• Uses minimally invasive techniques including Da Vinci robotic system
• Published research in molecular oncology and gynecological treatments

Prof. Köstler specializes in breast cancer immunotherapy, combining over 22 years of experience of clinical experience with cutting-edge research at Wiener Privatklinik.

• Expert in targeted therapies and personalized cancer medicine
• Associate Professor at Medical University of Vienna
• Focuses on biomarker development and resistance mechanisms
• Published in leading international oncology journals

Specializes in breast, lung, and gastrointestinal cancers – Dr. Ozatli brings a focused approach to immunotherapy at Istinye Liv University Hospital.

• Associate Professor since 2016, recognized for expertise
• Treats complex cases at leading oncology center
• Background in multiple Turkish oncology departments
• Trained at Selcuk University's Faculty of Medicine

Expert in oncoplastic breast surgery and ROLL/SLNB techniques – Dr. Zengel brings precision to breast cancer care at Medicalpoint International Hospital.

• 12 years of experience of experience in breast surgery and oncology
• Specializes in skin and breast-conserving mastectomies with reconstruction
• Associate Professor of General Surgery with a doctorate in Basic Oncology
• Member of multiple professional associations including Izmir Breast Diseases Association

Professor Cemil Bilir specializes in medical oncology with international training at Cleveland Clinic and Northeastern University.

• Over 21 years of experience of experience in medical oncology
• Trained in the U.S. at prestigious institutions
• Member of ASCO and ESMO
• Currently serves as a professor at Sakarya University
• PhD candidate in inorganic chemistry, enhancing treatment approaches

Professor of Medical Oncology at Trakya University, specializing in breast cancer immunotherapy for over 29 years of experience.

• Fellowship-trained in medical oncology at Trakya University
• Associate Professor and then Professor of Medical Oncology from 2010 to present
• Extensive experience in treating breast cancer with immunotherapy

Dr. Alemdar specializes in medical oncology with a focus on breast cancer immunotherapy at Medical Park Antalya Hospital Complex.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University, a leading institution in Turkey
• Worked at multiple prestigious hospitals including Akdeniz University Hospital

Dr. Ercan Ozden specializes in immunotherapy for breast cancer at VM Medical Park Pendik Hospital, with extensive training in medical oncology.

• Graduated from Istanbul University, Cerrahpaşa Faculty of Medicine
• Completed internal medicine residency at the same institution
• Subspecialized in medical oncology at Kocaeli University Faculty of Medicine
• Practiced internal medicine at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital

Prof. Atci specializes in medical oncology with focused research on immunotherapy for breast cancer at Liv Hospital Topkapı.

• Published 19+ peer-reviewed studies on breast cancer treatments
• Member of American Society of Clinical Oncology (ASCO)
• Associate Professor of Medical Oncology at İstinye University
• Education Coordinator for Medical Oncology Sub-Branch

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Leading researcher in breast cancer subtypes – Dr. Prat focuses on translating lab findings into personalized immunotherapy approaches at Hospital Quiron Barcelona.

• Heads Translational Genomics Group at IDIBAPS
• President of SOLTI – designs clinical trials for novel breast cancer treatments
• Pioneer in gene expression analysis for tailored therapies
• Co-founded Reveal Genomics – holds three patents in cancer research

Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating, specializing in sarcoma and breast cancer immunotherapy at Nordwest Clinic.

• Head of Oncology and Hematology at Nordwest Clinic
• 41 years of experience of experience in oncology
• Recognized as a top sarcoma specialist